- Accueil >
- Publications >
- Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity
Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity
Auteurs
Z. Ajgal, S. de Percin, V. Diéras, J.Y. Pierga, F. Campana, A. Fourquet, Y.M. Kirova